세계의 소화관 치료제 시장 보고서(2025년)

Gastrointestinal therapeutics encompass a variety of drugs, biologics, and treatment options aimed at preventing, managing, or curing disorders of the gastrointestinal system, which includes the esophagus, stomach, intestines, liver, pancreas, and gallbladder. These treatments address conditions like acid reflux, ulcers, irritable bowel syndrome, Crohn's disease, and gastrointestinal cancers.

The primary categories of gastrointestinal therapeutics include over-the-counter (OTC) and prescription-based products. OTC gastrointestinal therapeutics consist of non-prescription medications designed to alleviate common digestive problems such as heartburn, indigestion, gas, constipation, and diarrhea. These therapies can be administered via different routes, including oral and intravenous methods. They are used to treat various conditions such as inflammatory bowel disease, gastroesophageal reflux disease, peptic ulcer disease, and irritable bowel syndrome. Distribution of these products occurs through hospital pharmacies, retail pharmacies, online pharmacies, and more. End users range from hospitals and clinics to ambulatory surgical centers and diagnostic laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The gastrointestinal therapeutics market research report is one of a series of new reports from The Business Research Company that provides gastrointestinal therapeutics market statistics, including gastrointestinal therapeutics global market size, regional shares, competitors with gastrointestinal therapeutics market share, detailed gastrointestinal therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal therapeutics industry. The gastrointestinal therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastrointestinal therapeutics market size has grown strongly in recent years. It will grow from $39.99 billion in 2024 to $42.30 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. Growth during the historic period was driven by increased government healthcare spending, higher rates of early diagnosis, expanded awareness campaigns about gut health, a rise in lifestyle-related digestive disorders, and the adoption of multidisciplinary treatment methods.

The gastrointestinal therapeutics market size is expected to see strong growth in the next few years. It will grow to $52.41 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. Growth in the forecast period is expected to result from increasing demand for biologics and targeted treatments, greater adoption of personalized medicine, a growing patient preference for combination therapies, increased focus on microbiome-targeted treatments, and a rise in antibiotic-related gastrointestinal complications. Key trends during this period include advancements in technology integration for endoscopic devices, development of microbiome-based therapies, the use of digital health and remote monitoring, incorporation of multi-omics data in therapy development, and innovations in acid suppression treatments.

The increasing prevalence of inflammatory bowel diseases is expected to drive the growth of the gastrointestinal therapeutics market in the future. Inflammatory bowel disease (IBD) is a chronic illness characterized by inflammation of the digestive tract, mainly including Crohn's disease and ulcerative colitis. The rise in IBD cases is linked to genetic susceptibility, which leads to an abnormal immune response to gut microbes. Gastrointestinal therapeutics work by targeting the underlying inflammation, regulating digestive functions, and easing symptoms to improve patient outcomes. For example, in December 2023, the IBD Registry, a UK-based non-profit organization, reported that over 5,300 individuals with inflammatory bowel diseases were registered in 2023, showing an increase of more than 3,000 members compared to 2022. Thus, the growing incidence of inflammatory bowel diseases is boosting the gastrointestinal therapeutics market.

Leading companies in the gastrointestinal therapeutics market are focusing on innovative treatments, such as sustained-release (SR) fixed-dose combination capsules, aimed at enhancing treatment effectiveness and patient adherence. Sustained-release (SR) fixed-dose combination capsules are oral drugs that gradually release multiple active ingredients over time, ensuring stable drug levels and reducing the need for frequent dosing. For instance, in June 2024, Akums Drugs and Pharmaceuticals Limited, an India-based pharmaceutical manufacturer, introduced rabeprazole + levosulpiride SR capsules for gastrointestinal disorders in India. This formulation pairs rabeprazole, a proton pump inhibitor that lowers stomach acid, with levosulpiride, a prokinetic that improves gut motility. Together, they provide relief from symptoms like heartburn, acid reflux, bloating, and indigestion, and are commonly prescribed for conditions such as gastroesophageal reflux disease, peptic ulcers, and related gastrointestinal issues.

In April 2023, Merck and Co., Inc., a US pharmaceutical company, acquired Prometheus Biosciences, Inc. for $10.8 billion. This acquisition is intended to strengthen Merck's immunology pipeline by advancing precision therapies for inflammatory diseases, including ulcerative colitis and Crohn's disease. Prometheus Biosciences, Inc., based in the US, specializes in precision therapeutics for immune-mediated disorders, particularly those affecting the gastrointestinal system.

Major players in the gastrointestinal therapeutics market are Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited., Boehringer Ingelheim International GmbH, Otsuka Holdings Co. Ltd., Daiichi Sankyo Company Limited., Bausch Health Companies Inc, Olympus Corporation, UCB S.A., Eisai Co. Ltd., Aurobindo Pharma Limited., Dr. Reddy's Laboratories Limited., Ironwood Pharmaceuticals Inc, Salix Pharmaceuticals Ltd., Ferring Pharmaceuticals A/S, Jubilant Pharma Limited., Sebela Pharmaceuticals Inc, Cosmo Pharmaceuticals N.V., Tillotts Pharma AG, Mitsubishi Tanabe Pharma Corporation.

North America was the largest region in the gastrointestinal therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastrointestinal therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gastrointestinal therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastrointestinal therapeutics market consists of sales of acid suppressants, antiemetic agents, antispasmodics, digestive enzymes, and prebiotics and probiotics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastrointestinal Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastrointestinal therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastrointestinal therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastrointestinal therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Over-The-Counter Gastrointestinal Therapeutics; Prescription-Based Gastrointestinal Therapeutics
• 2) By Route Of Administration: Oral; Intravenous; Other Routes Of Administration
• 3) By Application: Inflammatory Bowel Disease; Gastroesophageal Reflux Disease; Peptic Ulcer Disease; Irritable Bowel Syndrome; Other Applications
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Diagnostic Laboratories; Other End-Users
• Subsegments:
• 1) By Over-The-Counter Gastrointestinal Therapeutics: Antacids; Laxatives; Anti-Diarrheal Agents; Digestive Enzymes; Probiotics; H2-Receptor Antagonists; Simethicone Products
• 2) By Prescription-Based Gastrointestinal Therapeutics: Proton Pump Inhibitors; Antibiotics For H. pylori; Aminosalicylates; Biologics; Corticosteroids; Immunosuppressants; Antiemetics
• Companies Mentioned: Abbott Laboratories; Novartis AG; Takeda Pharmaceutical Company Limited.; Boehringer Ingelheim International GmbH; Otsuka Holdings Co. Ltd.; Daiichi Sankyo Company Limited.; Bausch Health Companies Inc; Olympus Corporation; UCB S.A.; Eisai Co. Ltd.; Aurobindo Pharma Limited.; Dr. Reddy's Laboratories Limited.; Ironwood Pharmaceuticals Inc; Salix Pharmaceuticals Ltd.; Ferring Pharmaceuticals A/S; Jubilant Pharma Limited.; Sebela Pharmaceuticals Inc; Cosmo Pharmaceuticals N.V.; Tillotts Pharma AG; Mitsubishi Tanabe Pharma Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gastrointestinal Therapeutics Market Characteristics

3. Gastrointestinal Therapeutics Market Trends And Strategies

4. Gastrointestinal Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Gastrointestinal Therapeutics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Gastrointestinal Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Gastrointestinal Therapeutics Market Growth Rate Analysis
• 5.4. Global Gastrointestinal Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Gastrointestinal Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Gastrointestinal Therapeutics Total Addressable Market (TAM)

6. Gastrointestinal Therapeutics Market Segmentation

• 6.1. Global Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Over-The-Counter Gastrointestinal Therapeutics
• Prescription-Based Gastrointestinal Therapeutics
• 6.2. Global Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Other Routes Of Administration
• 6.3. Global Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inflammatory Bowel Disease
• Gastroesophageal Reflux Disease
• Peptic Ulcer Disease
• Irritable Bowel Syndrome
• Other Applications
• 6.4. Global Gastrointestinal Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Gastrointestinal Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Diagnostic Laboratories
• Other End-Users
• 6.6. Global Gastrointestinal Therapeutics Market, Sub-Segmentation Of Over-The-Counter Gastrointestinal Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antacids
• Laxatives
• Anti-Diarrheal Agents
• Digestive Enzymes
• Probiotics
• H2-Receptor Antagonists
• Simethicone Products
• 6.7. Global Gastrointestinal Therapeutics Market, Sub-Segmentation Of Prescription-Based Gastrointestinal Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Proton Pump Inhibitors
• Antibiotics For H. pylori
• Aminosalicylates
• Biologics
• Corticosteroids
• Immunosuppressants
• Antiemetics

7. Gastrointestinal Therapeutics Market Regional And Country Analysis

• 7.1. Global Gastrointestinal Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Gastrointestinal Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gastrointestinal Therapeutics Market

• 8.1. Asia-Pacific Gastrointestinal Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gastrointestinal Therapeutics Market

• 9.1. China Gastrointestinal Therapeutics Market Overview
• 9.2. China Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gastrointestinal Therapeutics Market

• 10.1. India Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gastrointestinal Therapeutics Market

• 11.1. Japan Gastrointestinal Therapeutics Market Overview
• 11.2. Japan Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gastrointestinal Therapeutics Market

• 12.1. Australia Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gastrointestinal Therapeutics Market

• 13.1. Indonesia Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gastrointestinal Therapeutics Market

• 14.1. South Korea Gastrointestinal Therapeutics Market Overview
• 14.2. South Korea Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gastrointestinal Therapeutics Market

• 15.1. Western Europe Gastrointestinal Therapeutics Market Overview
• 15.2. Western Europe Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gastrointestinal Therapeutics Market

• 16.1. UK Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gastrointestinal Therapeutics Market

• 17.1. Germany Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gastrointestinal Therapeutics Market

• 18.1. France Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gastrointestinal Therapeutics Market

• 19.1. Italy Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gastrointestinal Therapeutics Market

• 20.1. Spain Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gastrointestinal Therapeutics Market

• 21.1. Eastern Europe Gastrointestinal Therapeutics Market Overview
• 21.2. Eastern Europe Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gastrointestinal Therapeutics Market

• 22.1. Russia Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gastrointestinal Therapeutics Market

• 23.1. North America Gastrointestinal Therapeutics Market Overview
• 23.2. North America Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gastrointestinal Therapeutics Market

• 24.1. USA Gastrointestinal Therapeutics Market Overview
• 24.2. USA Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gastrointestinal Therapeutics Market

• 25.1. Canada Gastrointestinal Therapeutics Market Overview
• 25.2. Canada Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gastrointestinal Therapeutics Market

• 26.1. South America Gastrointestinal Therapeutics Market Overview
• 26.2. South America Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gastrointestinal Therapeutics Market

• 27.1. Brazil Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gastrointestinal Therapeutics Market

• 28.1. Middle East Gastrointestinal Therapeutics Market Overview
• 28.2. Middle East Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gastrointestinal Therapeutics Market

• 29.1. Africa Gastrointestinal Therapeutics Market Overview
• 29.2. Africa Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gastrointestinal Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Gastrointestinal Therapeutics Market Competitive Landscape
• 30.2. Gastrointestinal Therapeutics Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Takeda Pharmaceutical Company Limited. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Otsuka Holdings Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Gastrointestinal Therapeutics Market Other Major And Innovative Companies

• 31.1. Daiichi Sankyo Company Limited.
• 31.2. Bausch Health Companies Inc
• 31.3. Olympus Corporation
• 31.4. UCB S.A.
• 31.5. Eisai Co. Ltd.
• 31.6. Aurobindo Pharma Limited.
• 31.7. Dr. Reddy's Laboratories Limited.
• 31.8. Ironwood Pharmaceuticals Inc
• 31.9. Salix Pharmaceuticals Ltd.
• 31.10. Ferring Pharmaceuticals A/S
• 31.11. Jubilant Pharma Limited.
• 31.12. Sebela Pharmaceuticals Inc
• 31.13. Cosmo Pharmaceuticals N.V.
• 31.14. Tillotts Pharma AG
• 31.15. Mitsubishi Tanabe Pharma Corporation

32. Global Gastrointestinal Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastrointestinal Therapeutics Market

34. Recent Developments In The Gastrointestinal Therapeutics Market

35. Gastrointestinal Therapeutics Market High Potential Countries, Segments and Strategies

• 35.1 Gastrointestinal Therapeutics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Gastrointestinal Therapeutics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Gastrointestinal Therapeutics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer